GlassScriptPhysician profile
Amy B Wechsler
NPI 1972690709
$2,360,071.78
in general payments reported to CMS, 2019-2025
5 companies · $378K in 2025
The $378K reported for 2025 was more than what 99% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382K · 2020: $328K · 2021: $131K · 2022: $379K · 2023: $381K · 2024: $380K · 2025: $378K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $555K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $478K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $100K · Travel and Lodging: $6,059 · Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $555,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $477,500.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $100,000.00 |
| Travel and Lodging | $6,059.44 |
| Food and Beverage | $1,115.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $2,359,940.67 | 2019-2025 | |
| Galderma Laboratories, L.P. | $55.87 | 2023-2025 | |
| Allergan, INC. | $32.84 | 2019-2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $24.89 | 2025 | |
| Sun Pharmaceutical Industries INC. | $17.51 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Wechsler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.